Bircan Kayaaslan to Hydroxychloroquine
This is a "connection" page, showing publications Bircan Kayaaslan has written about Hydroxychloroquine.
Connection Strength
0.051
-
Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir. J Infect Public Health. 2021 Mar; 14(3):365-370.
Score: 0.040
-
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients. BMC Infect Dis. 2021 May 04; 21(1):411.
Score: 0.010